Structural Formula (Cymbalta 01)
Cymbalta Capsule, Delayed Release
Product Images NDC 0002-3270
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 0002-3270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 3 (Cymbalta 02)
Figure 4 (Cymbalta 03)
Figure 5 (Cymbalta 13)
Figure 6 (Cymbalta 14)
Figure 7 (Cymbalta 15)
This is a chart showing the percentage of patients who improved while taking a placebo versus CYM60/120 mg once daily for pain relief. The percentage of improvement ranges from 0% to 100%. The X-axis shows the percentage improvement in pain from baseline (BOCF).*
Figure 8 (Cymbalta 16)
The text describes the percentage of patients improved using a placebo versus CYMB0 mg once daily. It includes a chart showing the percentage improvement in pain from baseline.*
Figure 9 (Cymbalta 17)
Figure 1 (Cymbalta 18)
The text appears to depict a graph showing the proportion of patients with relapse after treatment with either a placebo or a medication called Cymbalta. The x-axis represents the time (in days) from randomization to relapse, while the y-axis represents the proportion of patients. The graph shows that Cymbalta may have a lower proportion of patients experiencing relapse compared to the placebo, but without further context, it is difficult to assess the significance of this information.*
Figure 2 (Cymbalta 19)
Cymbalta 20
The text provides a graph showing the percentage of patients improved along with the percentage improvement in pain from baseline for a medication named 'Gymbalta' in comparison to a placebo. Not available information about the study, patients, or the medical condition treated.*
Cymbalta 20mg Contain 049 01
Cymbalta 30mg Contain 063 02
Cymbalta 60mg Contain 052 01
This text provides information on a medicine with the NDC code 0002-3270-30, which is available in the form of 30 capsules. The medication is called duloxetine capsules and each capsule contains 60 mg of the active ingredient. The text also includes the Rx only label, suggesting that this is a prescription medication. There is also some unclear text at the end, which reads "Soeazsc 15506 ot".*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
